Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides.
D000273:Adipose Tissue / Q000032:analysis / Q000187:drug effects*; D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002264:Carboxylic Acids / Q000494:pharmacology; D003345:Corticosterone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000097:blood*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008053:Lipid Mobilization / Q000187:drug effects*; D008099:Liver / Q000032:analysis; D008297:Male; D009206:Myocardium / Q000032:analysis; D009538:Nicotine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D014280:Triglycerides / Q000032:analysis*
D001786:Blood Glucose; D002264:Carboxylic Acids; D005230:Fatty Acids, Nonesterified; D011720:Pyrazoles; D014280:Triglycerides; D009538:Nicotine; D011433:Propranolol; D003345:Corticosterone